{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:23:37Z","timestamp":1791829417973,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.hlc.2024.03.010","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T12:45:51Z","timestamp":1714567551000},"page":"693-703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Echocardiography and Multi-Planar Gated Acquisition Scans for Predicting Cancer-Treatment-Related Cardiovascular Dysfunction"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8125-929X","authenticated-orcid":false,"given":"Mark T.","family":"Nolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0939-5470","authenticated-orcid":false,"given":"Faraz","family":"Pathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8646-1585","authenticated-orcid":false,"given":"Louise","family":"Nott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Pointon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9065-0899","authenticated-orcid":false,"given":"Thomas H.","family":"Marwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2024.03.010_bib1","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.hlc.2024.03.010_bib2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jacc.2020.11.020","article-title":"Strain-guided management of potentially cardiotoxic cancer therapy","volume":"77","author":"Thavendiranathan","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jacc.2009.03.095","article-title":"Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy","volume":"55","author":"Cardinale","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"Suppl 7","key":"10.1016\/j.hlc.2024.03.010_bib4","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hlc.2024.03.010_bib5","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jcmg.2018.06.005","article-title":"Cardiotoxicity and cardiac monitoring among chemotherapy-treated breast cancer patients","volume":"11","author":"Henry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2024.03.010_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00000421-199704000-00005","article-title":"The role of radionuclide angiocardiography in the treatment of patients receiving doxorubicin-based chemotherapy: a reassessment","volume":"20","author":"Dreicer","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.010_bib7","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12968-017-0348-4","article-title":"Accuracy of left ventricular ejection fraction by contemporary multiple gated acquisition scanning in patients with cancer: comparison with cardiovascular magnetic resonance","volume":"19","author":"Huang","year":"2017","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.hlc.2024.03.010_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.jcmg.2018.06.003","article-title":"Multi-modality imaging in the assessment of cardiovascular toxicity in the cancer patient","volume":"11","author":"Plana","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2024.03.010_bib9","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.010_bib10","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000421-200108000-00027","article-title":"Is MUGA scan necessary in patients with low-risk breast cancer before doxorubicin-based adjuvant therapy? Multiple gated acquisition","volume":"24","author":"Sabel","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.010_bib11","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1016\/j.nuclcard.2006.08.007","article-title":"Equilibrium radionuclide angiocardiography","volume":"13","author":"Corbett","year":"2006","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib12","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jacc.2012.09.035","article-title":"Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy","volume":"61","author":"Thavendiranathan","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib13","first-page":"1","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J\u00a0Stat Soft"},{"key":"10.1016\/j.hlc.2024.03.010_bib14","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s10549-021-06135-5","article-title":"Cardiac assessment in Australian patients receiving (neo)adjuvant trastuzumab for HER2-positive early breast cancer: a population-based study","volume":"187","author":"Tang","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.hlc.2024.03.010_bib15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10549-020-06039-w","article-title":"Cardiotoxicity during long-term trastuzumab use in patients with HER2-positive metastatic breast cancer: who needs cardiac monitoring?","volume":"186","author":"Bouwer","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.hlc.2024.03.010_bib16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jacc.2010.05.014","article-title":"Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis","volume":"56","author":"Chen","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib17","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0002-9149(97)89179-5","article-title":"Comparison and reproducibility of visual echocardiographic and quantitative radionuclide left ventricular ejection fractions","volume":"77","author":"van Royen","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.eurheartj.a015273","article-title":"Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function","volume":"18","author":"Otterstad","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2024.03.010_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jcmg.2012.11.017","article-title":"Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease","volume":"6","author":"Drafts","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2024.03.010_bib20","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1007\/s00330-006-0169-6","article-title":"Accurate estimation of global and regional cardiac function by retrospectively gated multidetector row computed tomography: comparison with cine magnetic resonance imaging","volume":"16","author":"Belge","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib21","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1016\/j.jacc.2018.08.2162","article-title":"Ejection fraction pros and cons: JACC state-of-the-art review","volume":"72","author":"Marwick","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2024.03.010_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.echo.2016.02.018","article-title":"Myocardial strain is associated with adverse clinical cardiac events in patients treated with anthracyclines","volume":"29","author":"Ali","year":"2016","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hlc.2024.03.010_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/ehjci\/jeaa339","article-title":"Anthracyclines and regional myocardial damage in breast cancer patients. A multicentre study from the Working Group on Drug Cardiotoxicity and Cardioprotection, Italian Society of Cardiology (SIC)","volume":"22","author":"Zito","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2024.03.010_bib24","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1200\/JCO.2006.10.4976","article-title":"Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer","volume":"25","author":"Pinder","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.010_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11897-022-00544-3","article-title":"LVEF by multigated acquisition scan compared to other imaging modalities in cardio-oncology: a systematic review","volume":"19","author":"Printezi","year":"2022","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.hlc.2024.03.010_bib26","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1200\/JCO.2009.26.7294","article-title":"Role of three-dimensional echocardiography in breast cancer: comparison with two-dimensional echocardiography, multiple-gated acquisition scans, and cardiac magnetic resonance imaging","volume":"28","author":"Walker","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.hlc.2024.03.010_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/01.CIR.62.1.126","article-title":"The reproducibility of radionuclide angiographic measurements of left ventricular function in normal subjects at rest and during exercise","volume":"62","author":"Upton","year":"1980","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2024.03.010_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","article-title":"Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity","volume":"26","author":"Negishi","year":"2013","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.hlc.2024.03.010_bib29","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","article-title":"Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab","volume":"5","author":"Sawaya","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2024.03.010_bib30","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1093\/eurheartj\/ehab674","article-title":"Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement","volume":"43","author":"Herrmann","year":"2022","journal-title":"Eur Heart J"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950624001720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T06:20:50Z","timestamp":1717654850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950624001720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1443950624001720"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.010","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Echocardiography and Multi-Planar Gated Acquisition Scans for Predicting Cancer-Treatment-Related Cardiovascular Dysfunction","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2024.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). All rights reserved.","name":"copyright","label":"Copyright"}]}}